The results demonstrated that the expression levels of FOXC1 in the AN3CA/miR-495 and KLE/miR-495 groups were reduced by approximately 70.5 % and 62.50 %, respectively, compared with the negative control (Fig. 5c), which were consistent with the results from endometrial cancer cells in vitro. The gene discussed is FOXC1; the disease is endometrial cancer.